Instituts de recherche en santé du Canada
570 556 captures · dernière capture : 3 mai 2026
Page d’accueil :https://cihr-irsc.gc.ca/f/193.html
Le français est une traduction alpha automatisée. Pour le texte officiel, consultez la version anglaise.
Explorateur d’archives
Parcourir et rechercher des captures
Note importante
Parcourez et recherchez des captures historiques. Ceci est une archive — pas des directives actuelles ni un avis médical. Le contenu archivé peut être incomplet, périmé ou remplacé. Pour des recommandations à jour, consultez toujours le site officiel de la source.
Pour plus de contexte sur la couverture et les méthodes de capture, voir Méthodes et couverture.
Parcourir les sites archivés
Santé Canada
386 223 captures · dernière capture : 14 avr. 2026
Page d’accueil :https://www.canada.ca/fr/sante-canada.html
Agence de la santé publique du Canada
243 880 captures · dernière capture : 28 avr. 2026
Page d’accueil :https://www.canada.ca/fr/sante-publique.html
Qualifying notice for Lunsumio (298079) Biologic and Radiopharmaceutical Drugs Directorate 100 Eglantine Driveway LCDC Building Tunney’s Pasture, A.L. 0601C Ottawa ON K1A 0K9 Dossier ID: e242454 Control number: 298079 [employee name removed] [employee title removed] Hoffmann-La…
Notice: Multiple additions to the Prescription Drug List (PDL) [2026-02-26] February 26, 2026 Our file number: 26-100917-526 The purpose of this Notice of Amendment is to announce the addition of nemolizumab, nipocalimab, olezarsen sodium, pegunigalsidase alfa, plozasiran,…
Nitrosamine impurities in medications: Established acceptable intake limits Overview Recalls Test methods and test results Guidance Established acceptable intake limits Report a problem or concern Established Acceptable Intake Limits (Excel version - (1.3 MB)) Health Canada's…
Addressing potential drug supply and shipping issues during the conflict in the Middle East Drug Establishment Licensing Bulletin 195, March 17, 2026 Health Canada is closely monitoring potential impacts to Canada’s drug supply due to the conflict in the Middle East and…
Pharmaceutical and Life Sciences Sector Task Force On this page About the task force Co-chair biographies About the task force The Pharmaceutical and Life Sciences Sector Task Force is a joint federal initiative led by Health Canada and Innovation, Science and Economic…
Generic submissions under review Notice to stakeholders As of March 20, 2026, the downloadable Excel version of the list is now in a highlighted section for improved visibility and easier access. How to access a list of generic drug submissions currently under review. View the…
Phenytoin sodium capsules and phenytoin chewable tablets in short supply: Notice Date published: April 1, 2026 On this page Background What we're doing What you can do Background Phenytoin sodium capsules and phenytoin chewable tablets are used to control seizures. Phenytoin…
Consultation: Canadian Access, Watch, Reserve classification of antimicrobial drugs for human use Current status: Open Opened on April 9, 2026, and will close to new input on June 8, 2026. Health Canada is seeking stakeholder feedback on the proposed Canadian Access, Watch,…
Final notice: Classification of topical products containing human-derived exosomes, human extracellular vesicles, or human cell-conditioned media On this page Background Rationale for the classification approach Scope Classification considerations Canadian regulatory context…
New website for health product shortages Drug Establishment Licensing Bulletin 193, January 22, 2026 The website for mandatory reporting of drug shortages and discontinuations by regulated parties has changed to Health Product Shortages Canada . All traffic from the old website…
Page 4297 sur 6399Affichage de 42961 à 42970 sur 63986
Version préliminaire : la couverture et les fonctionnalités sont encore en expansion.
